Teladoc Stock Drops On Q4 Earnings: The Details
Portfolio Pulse from Adam Eckert
Teladoc Health Inc (NYSE:TDOC) reported its Q4 earnings with a 4% year-over-year revenue increase to $660.5 million, missing estimates of $671.43 million. The company had a smaller-than-expected quarterly loss of 17 cents per share, against estimates of a 21-cent loss. Teladoc generated $93.6 million in free cash flow and expects Q1 revenue between $630 million and $645 million, below estimates of $672.87 million. Full-year revenue is projected to be between $2.635 billion and $2.735 billion, under the $2.77 billion estimate. Shares dropped 11.7% after hours to $18.10.
February 20, 2024 | 9:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Teladoc's Q4 earnings showed revenue growth but missed estimates, with a smaller-than-expected loss per share. The company's after-hours stock price fell 11.7% to $18.10.
The reported revenue miss and the subsequent negative after-hours stock price movement indicate a bearish short-term outlook for TDOC. Despite beating loss per share estimates, the lower-than-expected revenue forecast for Q1 and the full year could further pressure the stock.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100